U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07641504) titled 'A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain' on June 08.

Brief Summary: The main purpose of this study is to test the safety and efficacy of study drug for the treatment of chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Pain Low Back Pain

Intervention: DRUG: LY4065967

Administered orally.

DRUG: Placebo

Administered orally

Recruitment Status: N...